Pharmacy Service, Hospital Infantil Universitario Nino Jesus, Madrid, Spain
Pharmacy Service, Hospital San Juan Grande, Jeréz de la Frontera (Cádiz), Spain.
Eur J Hosp Pharm. 2024 Apr 23;31(3):234-239. doi: 10.1136/ejhpharm-2022-003468.
Many medication errors occur during care transitions, which are critical points for patient safety. There is strong evidence in favour of medication reconciliation as a strategy to avoid errors in adults, though few studies have been made in the paediatric setting. Likewise, no recommendations have been established for the selection and/or prioritisation of paediatric patients amenable to reconciliation.
A retrospective study was conducted involving patients subjected to reconciliation by a pharmacist on admission to hospital and who experienced at least one reconciliation error between January and November 2018. Univariable and multivariable analyses were performed to identify possible factors associated with reconciliation error, using a logistic regression model to determine the odds ratio (OR) with the corresponding 95% confidence interval (95% CI).
The group of patients with at least one reconciliation error included 334 patients, compared with the group of patients without reconciliation errors, which included 1426 patients. It was determined that schoolchildren and adolescent patients had a risk of presenting a reconciliation error on hospital admission that was more than double for younger patients (OR 2.32, 95% CI 1.26 to 4.25, and OR 2.68, 95% CI 1.44 to 4.99, respectively). This risk was multiplied by five if we compared polymedicated patients versus non-polymedicated patients (OR 4.48, 95% CI 3.35 to 5.99). Patients with a neurological or onco-haematological underlying disease had a 12 and 10 times higher risk of presenting a reconciliation error compared with patients with other types of underlying diseases (OR 11.97, 95% CI 7.57 to 18.92, and OR 9.96, 95% CI 6.09 to 16.28, respectively). Finally, patients with narrow therapeutic index medicines in their usual treatment had an almost three times greater risk of presenting a reconciliation error when admitted to the hospital, although this last factor was not determined as an independent risk factor as for the others (OR 2.98, 95% CI 2.22 to 3.99).
The paediatric population is characterised by a number of risk factors for reconciliation error. Knowledge of these factors can allow the prioritisation of medication reconciliation in a concrete group of patients. In order to generalise the results obtained in this study, they must be confirmed in other paediatric care settings involving larger samples and different types of patients.
许多用药错误发生在医疗护理交接期间,这是患者安全的关键环节。有强有力的证据表明,用药核对是避免成人用药错误的一种策略,尽管在儿科环境中进行的研究很少。同样,也没有为可进行核对的儿科患者的选择和/或优先排序制定建议。
本回顾性研究纳入了在 2018 年 1 月至 11 月期间接受药师入院时核对的患者,并在核对过程中至少出现一次核对错误。使用逻辑回归模型确定可能与核对错误相关的单变量和多变量分析,以确定优势比(OR)及其对应的 95%置信区间(95%CI)。
至少有一次核对错误的患者组包括 334 名患者,而无核对错误的患者组包括 1426 名患者。与年轻患者相比,学龄儿童和青少年患者入院时出现核对错误的风险增加了一倍以上(OR 2.32,95%CI 1.26 至 4.25,OR 2.68,95%CI 1.44 至 4.99)。如果我们将多药治疗患者与非多药治疗患者进行比较,这种风险则增加五倍(OR 4.48,95%CI 3.35 至 5.99)。与患有其他基础疾病的患者相比,患有神经或血液肿瘤学基础疾病的患者发生核对错误的风险分别增加了 12 倍和 10 倍(OR 11.97,95%CI 7.57 至 18.92,OR 9.96,95%CI 6.09 至 16.28)。最后,在接受常规治疗时使用治疗指数较窄药物的患者在入院时发生核对错误的风险几乎增加了三倍,尽管与其他因素相比,这最后一个因素并未被确定为独立的危险因素(OR 2.98,95%CI 2.22 至 3.99)。
儿科人群存在多种核对错误的危险因素。了解这些因素可以优先对特定患者群体进行药物核对。为了推广本研究中的结果,必须在涉及更大样本量和不同类型患者的其他儿科护理环境中进行验证。